Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Salicyl Alcohol Glucoside
1. 138-52-3
2. Salicoside
3. Salicine
4. D-(-)-salicin
5. Salicyl Alcohol Glucoside
6. D(-)-salicin
7. (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2h-pyran-3,4,5-triol
8. 2-(hydroxymethyl)phenyl Beta-d-glucopyranoside
9. Saligenin Beta-d-glucopyranoside
10. Saligenin-beta-d-glucopyranoside
11. D-salicin
12. Alpha-hydroxy-o-tolyl Beta-d-glucopyranoside
13. Salicinum
14. 2-(hydroxymethyl)phenyl-beta-d-glucopyranoside
15. Nsc 5751
16. O-(hydroxymethyl)phenyl Beta-d-glucopyranoside
17. Beta-d-glucopyranoside, 2-(hydroxymethyl)phenyl
18. Benzyl Alcohol, O-hydroxy-, O-glucoside
19. Ai3-19099
20. Spectrum1502255
21. B-d-glucopyranoside, 2-(hydroxymethyl)phenyl
22. Chebi:17814
23. Nsc-5751
24. D-()-salicin
25. (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol
26. 4649620tbz
27. Sdccgmls-0066698.p001
28. Ncgc00142605-01
29. Mfcd00006590
30. (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-(hydroxymethyl)-phenoxy)tetrahydro-2h-pyran-3,4,5-triol
31. Smr000112301
32. Salicin [usp]
33. Sr-05000001594
34. Salicin (6ci,8ci)
35. Einecs 205-331-6
36. Delta-salicin
37. Unii-4649620tbz
38. 2-(hydroxymethyl)phenyl Hexopyranoside
39. Saligenin Glucoside
40. Sa0
41. D-(?)-salicin
42. Spectrum_001230
43. 2-(hydroxymethyl)phenyl-.beta.-d-glucopyranoside
44. Salicin [inci]
45. Salicin [mi]
46. Salicinum [hpus]
47. Spectrum2_000756
48. Spectrum3_000948
49. Spectrum4_001058
50. Spectrum5_000971
51. Bmse000315
52. Salicyl Alcohol-b-glucoside
53. Saligenin Bet.-d-glucoside
54. D-salicin [usp-rs]
55. Schembl24936
56. Kbiogr_001356
57. Kbioss_001710
58. Saligenin-b-d-glucopyranoside
59. Mls000563050
60. Mls001306490
61. Divk1c_000030
62. S0625_sigma
63. Spbio_000772
64. Chembl462997
65. Megxp0_000685
66. Salicin (salicoside, Salicine)
67. Acon1_000373
68. Hms500b12
69. Kbio1_000030
70. Kbio2_001710
71. Kbio2_004278
72. Kbio2_006846
73. Kbio3_002016
74. Dtxsid10883326
75. Ninds_000030
76. Hms1921p08
77. Hms2092f14
78. Hms2268j11
79. Hms3884b15
80. Pharmakon1600-01502255
81. Hy-n0149
82. Saligenin Beta-delta-glucopyranoside
83. Saligenin-beta-delta-glucopyranoside
84. Zinc3847505
85. D-(-)-salicin, Analytical Standard
86. Ccg-40332
87. Nsc758201
88. S2351
89. Zinc03847505
90. Akos004907439
91. Ac-8042
92. Cs-8027
93. D-(-)-salicin, >=99% (gc)
94. Nsc-758201
95. Idi1_000030
96. Ncgc00142605-02
97. Ncgc00142605-04
98. (2s,4s,5s,3r,6r)-6-(hydroxymethyl)-2-[2-(hydroxymethyl)phenoxy]-2h-3,4,5,6-tet Rahydropyran-3,4,5-triol
99. Salicyl Alcohol Glucoside [who-dd]
100. Sbi-0051746.p002
101. 2(hydroxymethyl)phenyl-beta-d-glucopyranoside
102. N1880
103. S0003
104. Sw219123-1
105. C01451
106. 2-(hydroxymethyl)-phenyl-beta-d-glucopyranoside
107. 2-(hydroxymethyl)phenyl-&beta-d-glucopyranoside
108. 2-(hydroxymethyl)phenyl-o-beta-d-glucopyranoside
109. Ab00052296_07
110. 138s523
111. Q419173
112. Sr-05000001594-1
113. Sr-05000001594-2
114. Brd-k64614248-001-02-4
115. Brd-k64614248-001-06-5
116. Ead32be1-198e-432c-9f44-dc0dc9a3305b
117. Salicin, European Pharmacopoeia (ep) Reference Standard
118. D-salicin, United States Pharmacopeia (usp) Reference Standard
119. Wurcs=2.0/1,1,0/[a2122h-1b_1-5_1*o(c^zc^zc^zc^zc^zc^e$3)/4co]/1/
120. 2-(hydroxymethyl)phenyl-beta-d-glucopyranoside, Salicoside, Salicyl Alcohol Glucoside, Saligenin Beta-d-glucoside
Molecular Weight | 286.28 g/mol |
---|---|
Molecular Formula | C13H18O7 |
XLogP3 | -1.2 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 286.10525291 g/mol |
Monoisotopic Mass | 286.10525291 g/mol |
Topological Polar Surface Area | 120 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Salicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Salicin, including repackagers and relabelers. The FDA regulates Salicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Salicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Salicin supplier is an individual or a company that provides Salicin active pharmaceutical ingredient (API) or Salicin finished formulations upon request. The Salicin suppliers may include Salicin API manufacturers, exporters, distributors and traders.
Salicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Salicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Salicin GMP manufacturer or Salicin GMP API supplier for your needs.
A Salicin CoA (Certificate of Analysis) is a formal document that attests to Salicin's compliance with Salicin specifications and serves as a tool for batch-level quality control.
Salicin CoA mostly includes findings from lab analyses of a specific batch. For each Salicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Salicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Salicin EP), Salicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Salicin USP).
LOOKING FOR A SUPPLIER?